The role of regulatory CD4+CD25+high T-lymphocytes and their functional activity in the development of type 1 diabetes mellitus

Type 1 diabetes mellitus (DM1) is associated with compromised (defective) immunologic tolerance to autoantigens and selective destruction of pancreatic B-cells by CD4+ (effector) and CD8 (cytotoxic) lymphocytes. The mechanisms of autotolerance involve CD4+CD25+high T-regulatory cells (Treg) whose suppressor activity depends on the expression of the FoxP3 gene. Aim. Detection of quantitative and functional alterations at the level of regulation of immunity in subjects at risk of DM1 and patients with different duration of DM1. Materials and methods. 116 patients (67 men and 49 women) with different duration of DM1. The risk group was comprised of 33 subjects (10 men and 23 women), control group included 16 subjects. In all cases, HLA genotyping was performed, autoantibodies to GDC, insulin and tyrosine phosphatase, islet cell antigens were determined, subpopulation composition of CD3+, CD4+, CD8+, CD38+, HLA DR+, CD25+, CD4+25+ lymphocytes and their functional activities (FoxP3 gene expression) studied, C-peptie and HbA1c levels measured. Results. A tendency toward a rise in Cd25+ and CD4+25+ T-lymphocytes and a decrease in FoxP3 expression was documented in the risk group compared with control (p0.05) but their functional activity was lower (p

type 1 diabetes mellitus, subjects at risk if DM1, CD4+CD25+high regulatory T-lymphocytes, FoxP3 gene

1. Sakaguchi S., Sakaguchi N., Shimizu J. et al. Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance // Immunol. Rev. - 2001. - 182. - Р. 18-32.

2. Lan R.Y., Ansari A.A., Zhe-Xiong Lian, Eric M. Gershwin Regulatory T cells Development, function and role in autoimmunity // Autoimmunity Reviews. - 2005. - 4. - Р. 351-363.

3. Powell B.R., Buist N.R., Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy // J. Pediatr. - 1982. - V. 100. - P. 731-737.

4. Bennett C.L., Ochs H.D. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena // Curr. Opin. Pediatr. - 2001. - V. 13. - P. 533-538.

5. Gambineri E., Torgerson R.T., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis // Curr. Opin. Rheumatol. - 2003. - V. 15. - P. 430-435.

6. Fontenot J.D., Rasmussen J.P., Williams L.M. et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3 // Immunity. - 2005. - V. 22. - P. 329-341.

7. Pop S.M., Wong C.P., Culton D.A. et al. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes // J. Exp. Med. - 2005. - V. 201. - P. 1333-1346.

8. Zheng Y., Rudensky A.Y. FoxP3 in control of the regulatory T cell lineage // Nat. Immunol. - 2007. - V. 8. - P. 457-462.

9. Putnam A.L., Vendrame F., Dotta F., Gottlieb P.A. CD4+CD25+high regulatory T cells in human autoimmune diabetes // J. Autoimmun. - 2005. - V. 24. - P. 55-62.

10. Sakaguchi S., Sakaguchi N., Asano M. et al. Immunologic сell-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25) // J. Immunol. - 1995. - V. 155. - P. 1151-1164.

11. Fehervari Z., Sakaguchi S. CD4(+) Tregs and immune control // J. Clin. Invest. - 2004. - 114(9). - Р. 1209-1217.

12. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., Tree T.I. Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes // Diabetes. - 2005. - Vol. 54. - Р. 92-99.

13. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999 (WHO/NCD/NCS/99.2).

14. Jin Y., Chen X., Podolsky R. et al. APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes // Clin. Immunol. - 2008. - doi:10.1016/j.clim.2008.10.005.

15. Glisic-Milosavljevic S., Waukau J., Jailwala P., Jana S., Khoo H.-J., et al (2007). At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+high T-Cell Fraction // PLoS ONE 2(1): e146. doi:10.1371/journal.pone.0000146.

16. Hillebrands J.-L., Whalen B., Visser J.T.J. et al. A Regulatory CD4_ T Cell Subset in the BB Rat Model of Autoimmune Diabetes Expresses Neither CD25 Nor Foxp31 // The Journal of Immunology. - 2006. - 177. - Р. 7820-7832.